Till startsida
To content Read more about how we use cookies on gu.se

Key Publications

PubMed: Emma Börgeson

GUP Latest publications: Emma Börgeson

Meenu Rohin Rajan, Matus Sotak, Fredrik Barrenäs, Tong Shen, Kamil Borkowski, Nicholas J Ashton, Christina Biörserud, Tomas L Lindahl, Sofia Ramström, Michael Schöll et al.
Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum.
Scientific reports Oct 28;9(1):15385. (2019) doi: 10.1038/s41598-019-51673-0.

Key original papers

Börgeson E, Wallenius V, Syed GH, Darshi M, Lantero Rodriguez J, Biörserud C, Ragnmark Ek M, Björklund P, Quiding-Järbrink M, Fändriks L, Godson C, Sharma K.
AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin.
Diabetologia. 60(4):729-739 (2017). PMID: 28188334

Börgeson E, Johnsson A, Lee Y.S., Till A, Syed H, Ali-Shah, Guiry P, Dalli D, Colas R, Serhan CN, Godson C, Sharma K.
Lipoxin A4 attenuates obesity-induced adipose inflammation, liver and kidney disease.
Cell Metabolism. 7;22(1):125-37 (2015). PMID:26052006

Börgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, Roche HM, Godson C.
Lipoxin A4 attenuates adipose inflammation.
FASEB Journal. 26(10):4287-94 (2012). PMID: 22700871

Börgeson E, Docherty NG, Murphy M, Rodgers K, Ryan A, O'Sullivan TP, Guiry PJ, Goldschmeding R, Higgins DF, Godson C.
Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis.
FASEB Journal. 25(9):2967-79. (2011). PMID: 21628447

Börgeson E, Lönn J, Bergström I, Brodin VP, Ramström S, Nayeri F, Särndahl E, Bengtsson T.
Lipoxin A4 inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression.
Infection and Immunity 79(4):1489-97. (2011). PMID: 21263017

Key review papers

Börgeson E.
The role of lipoxins in cardiometabolic physiology and disease.
Cardiovascular Endocrinology Journal, October 28, doi: 10.1097/XCE.0000000000000068. (2015).

Börgeson E, Sharma K.
Obesity, immunomodulation and chronic kidney disease.
Current Opinion in Pharmacol. 13(4):618-24. (2013). PMID: 23751262

Börgeson E, Godson C.
Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications.
Frontiers in Immunology, 18;3:318. (2012). PMID: 23087692

Page Manager: Anna Hallén|Last update: 12/11/2019

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?